Introducing the 2021 Pennovation Accelerator Eco-Impact Cohort
The 2021 Pennovation Accelerator officially launched Monday, July 12th for the program's fourth summer!
Regional collaborations emerge to address the biomanufacturing workforce crisis
In Philadelphia alone, cell and gene therapy and gene editing companies are preparing to add more than 1,100 new employees per year for the next decade, a net gain of more than 6,000 new workers.
PACT Recognizes Technology, Healthcare and Life Sciences Innovation and Leaders in the Philadelphia Region at the 2021 Enterprise Awards
Philadelphia Alliance for Capital and Technologies culminated two days celebrating the region’s technology, healthcare and life sciences innovators and leaders at the 2021 Enterprise Awards.
NextUp: The Philly biotech company developing an in vivo approach to CAR T-Cell therapy
Interius BioTherapeutics just raised $76 million in seed funding to advance their clinical testing.
Webinar Recording: Tips from Early Stage Investors
Gain insight from Venture Capitalists who focus on investing in early stage University startups. Recorded on May 19, 2021.
IQ Motion Control is democratizing advanced servo capabilities
Former I-Corps participant, and current PennovationWorks tenant, IQ Motion Control announced the launch of their newest line of servo motors, the Fortiq BLS42.
Interius Therapeutics raises record-breaking Series A round
A two-year-old Philadelphia gene therapy company spun out of the University of Pennsylvania has raised $76 million
PCI’s Managing Director leads panel discussion on Cellicon Valley with Penn Medicine faculty luminaries
On May 6th, as part of the Cellicon Valley '21 two-day event, John Swartley, Managing Director of PCI, joined Penn Medicine faculty to discuss the commercialization of CAR-T technology